Episodes 46-60 of 590
COVID-19 Risks in Infants: The Case for Maternal Vaccination
Clinician's RoundtableCOVID-19 Risks in Infants: The Case for Maternal Vaccination
COVID-19 in Pregnant Individuals and Children: Vaccine Access and Advocacy
Clinician's RoundtableCOVID-19 in Pregnant Individuals and Children: Vaccine Access and Advocacy
Rethinking Contact Lenses for Myopic Kids: Why Age 7 Isn’t Too Young
Eye on Ocular HealthRethinking Contact Lenses for Myopic Kids: Why Age 7 Isn’t Too Young
Debunking Myopia Myths: Kids Are Safer Contact Lens Wearers Than You May Think
Eye on Ocular HealthDebunking Myopia Myths: Kids Are Safer Contact Lens Wearers Than You May Think
Moving Beyond Correction: WCO’s Standard of Care for Myopia Management
Eye on Ocular HealthMoving Beyond Correction: WCO’s Standard of Care for Myopia Management
Pediatric Sickle Cell Disease: Analyzing Trends in Medication Utilization
Project Oncology®Pediatric Sickle Cell Disease: Analyzing Trends in Medication Utilization
- advertisement
Evaluating Guselkumab for Pediatric Psoriasis: New Phase III Trial Data
DermConsultEvaluating Guselkumab for Pediatric Psoriasis: New Phase III Trial Data
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
NeuroFrontiersExploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
Quantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
NeuroFrontiersQuantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
NeuroFrontiersCardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
Improving Health Literacy to Empower Adolescents With Sickle Cell Disease
Project Oncology®Improving Health Literacy to Empower Adolescents With Sickle Cell Disease
Cardiac Complications in Sickle Cell Disease: Emerging Evidence and Risks
Project Oncology®Cardiac Complications in Sickle Cell Disease: Emerging Evidence and Risks
- advertisement
Balancing Benefits and Risks in Emerging Sickle Cell Therapies
Project Oncology®Balancing Benefits and Risks in Emerging Sickle Cell Therapies
The Transition from Pediatric to Adult Care for Patients with Sickle Cell Disease
Project Oncology®The Transition from Pediatric to Adult Care for Patients with Sickle Cell Disease
Sickle Cell Disease Care: Examining Hydroxyurea and Chronic Transfusions
Project Oncology®Sickle Cell Disease Care: Examining Hydroxyurea and Chronic Transfusions
